Dr. Reddy's launches generic Zemplar

HYDERABAD, India — Dr. Reddy's Labs on Wednesday announced that it has launched paricalcitol capsules in 1-mcg, 2-mcg and 4-mcg dosage strengths. The drug is the generic version of Zemplar (paricalcitol) capsules.



The Zemplar brand and generic version had U.S. sales of approximately $109.6 million for the 12 months ending March 2014, according to IMS Health.